Code | 9547D | ||||||||||
MA number | EU/1/22/1625/001 | ||||||||||
Product Form: | tbl flm 30 (20x150 mg+10x100 mg) (blis.OPA/Al/PVC) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Pfizer Europe MA EEIG, Belgium | ||||||||||
Therapeutic Class: | 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | blister OPA/Al/PVC | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 28.01.2022 |
Validity: | 24.02.2028 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | infolist_Paxlovid_Shelf Life extension_24 mes_ dalsie sarze_04-10-2023.pdf |
Dokument: | DHPC_Paxlovid_21.03.2024.pdf |
Safety feature | Unknown |
Data update: | 01.03.2023 |